FDA DEVICE FACTS
Nitrile Examination Gloves, Powder Free [Purple] Tested for Use with Chemotherapy Drugs
Brightway Holdings Sdn. Bhd.
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
BRIGHTWAY BRAND NITRILE EXAMINATION GLOVES, POWDER FREE [PURPLE] TESTED FOR USE WITH CHEMOTHERAPY DRUGS is a disposable device intended for medical purpose worn on the examiners hand or finger to prevent contamination between patient and examiner.
The tested chemotherapy drugs and their breakthrough detection times are as follows :
Test Chemotherapy Drug Name and Concentration Minimum Breakthrough Detection Time * Blenoxane (15mg/ml),(15,000 ppm) >240 Minutes * Busulfan(6mg/ml),(6,000 ppm) >240 Minutes » Carmustine (BCNU) (3.3mg/ml),(3,300 ppm) 3.6 Minutes » Cisplatin(1.0mg/ml), (1,000 ppm) >240 Minutes * Cyclophosphamide/Cytoxan(20mg/ml), (20,000 ppm) >240 Minutes * Cytarabine(100mg/ml), (100,000 ppm) >240 Minutes * Dacarbazine(DTIC) 10mg/ml, (10,000 ppm) >240 Minutes * Daunorubicin(Smg/ml), (5,000 ppm) >240 Minutes * Docetaxel(10mg/ml), (10,000 ppm) >240 Minutes * Doxorubicin HCL(2mg/ml),(2,000 ppm) >240 Minutes * Ellence (2mg/ml), (2,000 ppm) >240 Minutes * Etoposide /Toposar (20mg/ml), (20,000 ppm) >240 Minutes * Fludarabine (25mg/ml), (25,000 ppm) >240 Minutes » Fluorouracil(SOmg/ml), (50,000 ppm) >240 Minutes * Gemcitabine (38mg/ml), (38,000 ppm) >240 Minutes + Idarubicin(1.0mg/ml), (1,000 ppm) >240 Minutes * Ifosfamide (SOmg/ml), (50,000 ppm) >240 Minutes * Irinotecan(20mg/ml), (20,000 ppm) >240 Minutes * Mechlorethamine HCI(1.0mg/ml), (1,000 ppm) >240 Minutes * Melphalan(5mg/ml), (5,000 ppm) >240 Minutes * Methotrexate(25mg/ml),(25,000 ppm) >240 Minutes + Mitomycin C(0.5 mg/ml), (500 ppm) >240 Minutes * Mitoxantrone(2mg/ml),(2,000 ppm) >240 Minutes ° Paclitaxel(6.0mg/ml),(6,000 ppm) >240 Minutes * Paraplatin (10mg/ml),(10,000 ppm) >240 Minutes » Rituximab(10mg/ml),(10,000 ppm) >240 Minutes * Thiotepa (10mg/ml),(10,000 ppm) 15.9 Minutes * Trisenox(0.1mg/ml), (100 ppm) >240 Minutes * Vincristine Sulfate(1.0mg/ml),(1,000 ppm) >240 Minutes
Please note that Carmustine and Thiotepa have extremely low permeation times of 3,6 minutes and 15.9 minutes, respectively
WARNING: Do Not Use With : Carmustine, ThioTEPA
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。